“Proteasome inhibitors: beyond NFKB inhibition alone and the emerging role of combination therapy in the treatment of multiple myeloma”, Hematol Meeting Rep, vol. 2, no. 5, Jun. 2009, doi: 10.4081/hmr.v2i5.753.